7.905USD-1.00%Mkt Cap: 1.83B USDP/E: 11.60Last update: 2026-06-01
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internat…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap1.83B USD
Enterprise Value43.60B USD
Revenue (TTM)509.86M USD
Gross Profit292.76M USD
Net Income (TTM)146.93M USD
Revenue/Share2.143 USD
Last Price7.905 USD
Fiscal Year EndDec 2025
MR QuarterMar 2021
Employees640
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)11.60
P/E (Forward)7.55
PEG—
EV/EBITDA202.94
EV/Revenue85.51
P/S3.63
P/B4.75
EPS (TTM)0.68
EPS (Forward)1.06
52W Range
7.2105% of range22.37
52W High22.37 USD
52W Low7.210 USD
Profitability
Gross Margin57.39%
Oper. Margin-123.39%
EBITDA Margin42.13%
Profit Margin28.80%
ROE30.78%
ROA23.54%
Growth
Revenue Growth15.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.40M USD
CapEx (TTM)22.89M USD
FCF Margin11.45%
FCF Yield3.19%
Net Debt41.75B USD
Net Debt/EBITDA194.34
Balance Sheet
Debt/Equity0.17
Current Ratio6.95
Quick Ratio3.73
Book Value/Sh1.680 USD
Cash/Share241.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)16.75 USD
Target Range12.00 USD – 20.00 USD
# Analysts4
Ownership
Shares Out.231.77M
Float226.73M
Insiders1.87%
Institutions93.81%
Short Interest
Short Ratio2.6d
Short % Float10.55%
Short % Out.8.63%
Shares Short19.99M
Short (prev mo.)19.31M
Technical
SMA 509.946 (-20.5%)
SMA 20015.00 (-47.3%)
Beta0.82
S&P 52W Chg27.94%
Avg Vol (30d)5.71M
Avg Vol (10d)3.40M
Technical Indicators
RSI (14)31.1
MACD-0.6634
MACD Signal-0.6948
MACD Hist.+0.0314
BB Upper10.39 USD
BB Middle8.686 USD
BB Lower6.979 USD
BB Width39.31%
ATR (14)0.4555 USD
Vol Ratio (20d)0.19x